Reduced glucocerebrosidase activity in monocytes from patients with Parkinson’s disease

to related objects

Location: Deutsche Nationalbibliothek Frankfurt am Main

ISSN: 2045-2322

Extent: Online-Ressource

Language: Englisch

Notes: online resource.

Bibliographic citation: Reduced glucocerebrosidase activity in monocytes from patients with Parkinson’s disease ; volume:8 ; number:1 ; day:18 ; month:10 ; year:2018 ; pages:1-12 ; date:12.2018
Scientific reports ; 8, Heft 1 (18.10.2018), 1-12, 12.2018

Creator: Atashrazm, Farzaneh

Contributor: Hammond, Deborah
Perera, Gayathri
Dobson-Stone, Carol
Mueller, Nicole
Pickford, Russell
Kim, Woojin Scott
Kwok, John B.
Lewis, Simon J. G.
Halliday, Glenda M.
Dzamko, Nicolas
SpringerLink (Online service)

DOI: 10.1038/s41598-018-33921-x

URN: urn:nbn:de:101:1-2018111717030450485565

Rights: Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.

Last update: 14.08.2025, 11:00 AM CEST

Data provider

This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.

Show original at data provider

Associated

Atashrazm, Farzaneh
Hammond, Deborah
Perera, Gayathri
Dobson-Stone, Carol
Mueller, Nicole
Pickford, Russell
Kim, Woojin Scott
Kwok, John B.
Lewis, Simon J. G.
Halliday, Glenda M.
Dzamko, Nicolas
SpringerLink (Online service)

Other Objects (12)

Reduced penetrance of Parkinson’s disease models

Reduced habit-driven errors in Parkinson’s Disease

Physical activity profiles in Parkinson’s disease

Transcriptome deregulation of peripheral monocytes and whole blood in GBA-related Parkinson’s disease

Reduced synaptic activity and dysregulated extracellular matrix pathways in midbrain neurons from Parkinson’s disease patients

α-Synuclein-containing erythrocytic extracellular vesicles: essential contributors to hyperactivation of monocytes in Parkinson’s disease

Early-stage idiopathic Parkinson’s disease is associated with reduced circular RNA expression

Reduced workforce participation 5 years prior to first Parkinson’s disease sick-leave

Reduced sphingolipid hydrolase activities, substrate accumulation and ganglioside decline in Parkinson’s disease

Precision medicine in Parkinson’s disease: emerging treatments for genetic Parkinson’s disease

Nutraceuticals in Parkinson’s Disease

Redefinition of Parkinson’s Disease

Reduced penetrance of Parkinson’s disease models

Reduced habit-driven errors in Parkinson’s Disease

Physical activity profiles in Parkinson’s disease

Transcriptome deregulation of peripheral monocytes and whole blood in GBA-related Parkinson’s disease

Reduced synaptic activity and dysregulated extracellular matrix pathways in midbrain neurons from Parkinson’s disease patients

α-Synuclein-containing erythrocytic extracellular vesicles: essential contributors to hyperactivation of monocytes in Parkinson’s disease

Early-stage idiopathic Parkinson’s disease is associated with reduced circular RNA expression

Reduced workforce participation 5 years prior to first Parkinson’s disease sick-leave

Reduced sphingolipid hydrolase activities, substrate accumulation and ganglioside decline in Parkinson’s disease

Precision medicine in Parkinson’s disease: emerging treatments for genetic Parkinson’s disease

Nutraceuticals in Parkinson’s Disease

Redefinition of Parkinson’s Disease

Reduced penetrance of Parkinson’s disease models

Reduced habit-driven errors in Parkinson’s Disease

Physical activity profiles in Parkinson’s disease

Transcriptome deregulation of peripheral monocytes and whole blood in GBA-related Parkinson’s disease

Reduced synaptic activity and dysregulated extracellular matrix pathways in midbrain neurons from Parkinson’s disease patients

α-Synuclein-containing erythrocytic extracellular vesicles: essential contributors to hyperactivation of monocytes in Parkinson’s disease

Early-stage idiopathic Parkinson’s disease is associated with reduced circular RNA expression

Reduced workforce participation 5 years prior to first Parkinson’s disease sick-leave

Reduced sphingolipid hydrolase activities, substrate accumulation and ganglioside decline in Parkinson’s disease

Precision medicine in Parkinson’s disease: emerging treatments for genetic Parkinson’s disease

Nutraceuticals in Parkinson’s Disease

Redefinition of Parkinson’s Disease

Cultural heritage institutions wishing to register will find more information here.

Fields marked * need to be filled in.

Username*

Please enter your username

Email*

Please enter your email address

Please do not fill this field

First name

Last name

Password*

Please enter your password

Confirm password*

Please enter the same password

I have read the terms of use and the privacy policy for the collection of personal data and accept them. *

This field is required.

I would like to subscribe to the newsletter of the Deutsche Digitale Bibliothek. See newsletter subscription info.

Account created

Your "My DDB" account has been successfully created. Before you can log in to your account, you must click the confirmation link in the message we just sent to the email address you provided.

Reduced glucocerebrosidase activity in monocytes from patients with Parkinson’s disease

Object Details

References and Relationships

Contributors, Places and Time

Further information

Data provider

Associated

Other Objects (12)

Reduced penetrance of Parkinson’s disease models

Reduced habit-driven errors in Parkinson’s Disease

Physical activity profiles in Parkinson’s disease

Transcriptome deregulation of peripheral monocytes and whole blood in GBA-related Parkinson’s disease

Reduced synaptic activity and dysregulated extracellular matrix pathways in midbrain neurons from Parkinson’s disease patients

α-Synuclein-containing erythrocytic extracellular vesicles: essential contributors to hyperactivation of monocytes in Parkinson’s disease

Early-stage idiopathic Parkinson’s disease is associated with reduced circular RNA expression

Reduced workforce participation 5 years prior to first Parkinson’s disease sick-leave

Reduced sphingolipid hydrolase activities, substrate accumulation and ganglioside decline in Parkinson’s disease

Precision medicine in Parkinson’s disease: emerging treatments for genetic Parkinson’s disease

Nutraceuticals in Parkinson’s Disease

Redefinition of Parkinson’s Disease

Reduced penetrance of Parkinson’s disease models

Reduced habit-driven errors in Parkinson’s Disease

Physical activity profiles in Parkinson’s disease

Transcriptome deregulation of peripheral monocytes and whole blood in GBA-related Parkinson’s disease

Reduced synaptic activity and dysregulated extracellular matrix pathways in midbrain neurons from Parkinson’s disease patients

α-Synuclein-containing erythrocytic extracellular vesicles: essential contributors to hyperactivation of monocytes in Parkinson’s disease

Early-stage idiopathic Parkinson’s disease is associated with reduced circular RNA expression

Reduced workforce participation 5 years prior to first Parkinson’s disease sick-leave

Reduced sphingolipid hydrolase activities, substrate accumulation and ganglioside decline in Parkinson’s disease

Precision medicine in Parkinson’s disease: emerging treatments for genetic Parkinson’s disease

Nutraceuticals in Parkinson’s Disease

Redefinition of Parkinson’s Disease

Reduced penetrance of Parkinson’s disease models

Reduced habit-driven errors in Parkinson’s Disease

Physical activity profiles in Parkinson’s disease

Transcriptome deregulation of peripheral monocytes and whole blood in GBA-related Parkinson’s disease

Reduced synaptic activity and dysregulated extracellular matrix pathways in midbrain neurons from Parkinson’s disease patients

α-Synuclein-containing erythrocytic extracellular vesicles: essential contributors to hyperactivation of monocytes in Parkinson’s disease

Early-stage idiopathic Parkinson’s disease is associated with reduced circular RNA expression

Reduced workforce participation 5 years prior to first Parkinson’s disease sick-leave

Reduced sphingolipid hydrolase activities, substrate accumulation and ganglioside decline in Parkinson’s disease

Precision medicine in Parkinson’s disease: emerging treatments for genetic Parkinson’s disease

Nutraceuticals in Parkinson’s Disease

Redefinition of Parkinson’s Disease

Related objects

Reset password